KemPharm Inc. | Mutual Funds
Mutual Funds that own KemPharm Inc.
Vanguard Total Stock Market Index Fund
255,572
1.59%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
185,181
1.14%
40,700
0%
07/31/2018
77,930
0.49%
0
0.16%
06/30/2018
Fidelity Spartan Extended Market Index Fund
54,249
0.34%
0
0%
07/31/2018
Inver-99, SICAV
47,481
0.3%
15,101
6.11%
03/31/2018
Balaguer 98 de Inversiones, SICAV
39,853
0.25%
7,473
5.21%
03/31/2018
iShares Micro Cap ETF
33,437
0.21%
0
0.02%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
22,782
0.14%
0
0%
07/31/2018
Vanguard Balanced Index Fund
12,000
0.08%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
9,786
0.06%
0
0%
07/31/2018
| Address |
1180 Celebration Boulevard
Celebration Florida 34747
United States
|
|
Employees
|
- |
| Website |
http://www.kempharm.com |
| Updated |
07/08/2019 |
| KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. |
